Self-assembled metal-phenolic nanocomplexes comprised of green tea catechin for tumor-specific ferroptosis

Min Wang1, Aoling Yu1, Wen Han1

  • 1MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, College of Chemistry, Fuzhou University, Fuzhou, Fujian, 350116, China.

Materials Today. Bio
|April 9, 2024
PubMed

Insights

This study introduces novel nanocomplexes (FeE@PEG NPs) that induce ferroptosis, a cell death pathway, in tumor cells. These nanoparticles overcome tumor microenvironment challenges to enhance cancer therapy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Ferroptosis, a regulated cell death, is a promising cancer therapy target.
  • Tumor microenvironments often inhibit ferroptosis due to high glutathione (GSH) and low hydrogen peroxide (H2O2).

Purpose of the Study:

  • To develop a novel nanocomplex for targeted ferroptosis induction in tumors.
  • To overcome the challenges posed by the tumor microenvironment for effective cancer treatment.

Main Methods:

  • Self-assembled nanocomplexes (FeE NPs) were constructed using epigallocatechin-3-gallate (EGCG) and Fe3+ ions.
  • PEGylation yielded FeE@PEG NPs with enhanced biocompatibility and tumor-inhibitory properties.
  • FeE@PEG NPs were designed to disassemble in the tumor microenvironment, releasing Fe3+ and EGCG.

Main Results:

  • Released Fe3+ generates hydroxyl radicals (•OH) via Fenton reactions, inducing lipid peroxidation and ferroptosis.
  • Released EGCG produces H2O2, further promoting •OH generation and lipid peroxidation.
  • EGCG depletes intracellular GSH, causing redox imbalance and triggering ferroptosis in tumor cells.

Conclusions:

  • FeE@PEG NPs effectively induce ferroptosis in tumor cells by addressing TME-related limitations.
  • This rational material design offers a promising strategy for advancing anticancer ferroptosis therapy.